Back Stocks profile

Stock analysis tool for investors

Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA | BSE:524715

₹1473.70 -30.30 (-2.01%) 1D

Pharmaceuticals & Biotechnology

View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

1467.00

Today’s High

1488.00

52W low

977.30

52W High

1638.80

Open Price

1488.00

Prev. Close

1472.7000

Volume

3201334.00

Value

4717805915.80

Fundamentals

Market Cap Cr

353590.00

Price to Earnings

36.90

Price to Book Value

5.30

Dividend Yield

0.80

PE to Growth

2.80

Op Revenue TTM Cr

48496.85

Net Profit TTM Cr

9576.38

Cash From Operating Activity Cr

12134.98

Return on Equity %

15.04

EMA & SMA

Bullish Moving Averages

3

Bearish Moving Averages

13

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

19 Jun, 2024

57.2

Week

60.3

Month

58

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

1511.28

PIVOT

First Resistance

1522.57

Second Resistance

1541.13

Third Resistance

1552.42

First Support

1492.72

Second Support

1481.43

Third Support

1462.87

Relative Strength Index

50.44

Money Flow Index

48.02

MACD

-0.57

MACD Signal

-6.49

Average True Range

32.06

Average Directional Index

24.97

Rate of Change (21)

-1.82

Rate of Change (125)

21.71

Commodity Channel Index

70.3

Williams %R

-16.9

BETA

1 Month

0.34

3 Month

0.52

1 Year

0.4

3 Year

0.12

PRICE CHANGE ANALYSIS

-2.2%

1 Week

Low

High

1467

1529.85

-3.8%

1 Month

Low

High

1377.2

1564

-4.83%

3 Months

Low

High

1377.2

1638.85

18.37%

6 Months

Low

High

1208.55

1638.85

47.11%

1 Year

Low

High

977.3

1638.85

Bigul
20 Jun 2024

Sun Pharma receives warning letter from USFDA for Dadra facility

Letter lists violations of Current Good Manufacturing Practice regulations by the facility
Bigul
19 Jun 2024

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Of 32Nd Annual General Meeting And Connected Matters

Friday, July 12, 2024 is fixed as the Record Date for Payment of Final Dividend for FY 2023-24.
Bigul
19 Jun 2024

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Of 32Nd Annual General Meeting And Connected Matters

Intimation of 32nd Annual General Meeting and Connected Matters
Bigul
18 Jun 2024

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation regarding issuance of letter of confirmation in lieu of share certificates.
Bigul
14 Jun 2024

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Oral Presentation at EULAR 2024 of Data from Global Phase 2b Clinical Trial Demonstrates Durability of Pain Relief After a SIngle Injection of MM-II in Patients with Painful Knee Osteoarthritis (OA)
14 Jun 2024

Sun Pharma - Specialty To Drive Future Growth: Nirmal Bang

FY24 revenue increased by 10.4% to Rs 477,585 million, with improved gross margin and a rise in market share from 8.3% to 8.5%.
See all News

FAQs

The latest market price of Sun Pharmaceutical Industries Ltd. on NSE was Rs. 1473.70 as of today.

The opening share price of Sun Pharmaceutical Industries Ltd. was Rs. 1488.00 as of today.

The 52-week high share price of Sun Pharmaceutical Industries Ltd. was Rs. 1638.80.

The 52 week low share price of Sun Pharmaceutical Industries Ltd. was Rs. 977.30.

Sun Pharmaceutical Industries Ltd. has a market cap of Rs. 353590.00 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Sun Pharmaceutical Industries Ltd. is 2.80. Please refer to the Fundamentals section for further details.

The operating revenue for Sun Pharmaceutical Industries Ltd. in the last FY was Rs.  48496.85 crore. Please refer to the Financials section for further details.

The Net Profit for Sun Pharmaceutical Industries Ltd. in the last FY was Rs. 9576.38 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Sun Pharmaceutical Industries Ltd. was on 2024-02-09 for Rs. 8.5 per share. According to today’s share price, the dividend yield of Sun Pharmaceutical Industries Ltd. stands at 0.80. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Sun Pharmaceutical Industries Ltd. was as of 2013-07-29. The bonus ratio declared in this issue was 1:1. Please refer to the Corporate Actions section for further details.

The latest split issue declared by Sun Pharmaceutical Industries Ltd. was as of 2003-01-13. The split ratio declared in this issue was 10:5. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Sun Pharmaceutical Industries Ltd..

Close

Let's Open Free Demat Account